BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31724500)

  • 1. Nanophytomedicine Based Novel Therapeutic Strategies in Liver Cancer.
    Kumar S; Fayaz F; Pottoo FH; Bajaj S; Manchanda S; Bansal H
    Curr Top Med Chem; 2020; 20(22):1999-2024. PubMed ID: 31724500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
    Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
    Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis.
    Mann CD; Neal CP; Garcea G; Manson MM; Dennison AR; Berry DP
    Eur J Cancer Prev; 2009 Feb; 18(1):13-25. PubMed ID: 19077560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytofabrication of Nanoparticles as Novel Drugs for Anticancer Applications.
    Wei QY; He KM; Chen JL; Xu YM; Lau ATY
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemicals based chemopreventive and chemotherapeutic strategies and modern technologies to overcome limitations for better clinical applications.
    Singh VK; Arora D; Ansari MI; Sharma PK
    Phytother Res; 2019 Dec; 33(12):3064-3089. PubMed ID: 31515899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview of Natural Plant Products in the Treatment of Hepatocellular Carcinoma.
    Rawat D; Shrivastava S; Naik RA; Chhonker SK; Mehrotra A; Koiri RK
    Anticancer Agents Med Chem; 2018; 18(13):1838-1859. PubMed ID: 29866017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma.
    Hu B; Sun D; Sun C; Sun YF; Sun HX; Zhu QF; Yang XR; Gao YB; Tang WG; Fan J; Maitra A; Anders RA; Xu Y
    Biochem Biophys Res Commun; 2015 Dec; 468(4):525-32. PubMed ID: 26482853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
    Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
    J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals.
    Li C; Zhang J; Zu YJ; Nie SF; Cao J; Wang Q; Nie SP; Deng ZY; Xie MY; Wang S
    Chin J Nat Med; 2015 Sep; 13(9):641-52. PubMed ID: 26412423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of curcumin with other phytochemicals improves anticancer activity by regulating multiple molecular targets.
    Ghobadi N; Asoodeh A
    Phytother Res; 2023 Apr; 37(4):1688-1702. PubMed ID: 36883534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation.
    Cione E; La Torre C; Cannataro R; Caroleo MC; Plastina P; Gallelli L
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31878082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment.
    Singh A; Shafi S; Upadhyay T; Najmi AK; Kohli K; Pottoo FH
    Curr Top Med Chem; 2020; 20(20):1839-1854. PubMed ID: 32579503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral permeability of Trans-Resveratrol using nanocochleates for boosting anticancer efficacy; in-vitro and ex-vivo appraisal.
    El-Melegy MG; Eltaher HM; Gaballah A; El-Kamel AH
    Eur J Pharm Biopharm; 2021 Nov; 168():166-183. PubMed ID: 34481049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
    Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
    J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
    Aras A; Khokhar AR; Qureshi MZ; Silva MF; Sobczak-Kupiec A; Pineda EA; Hechenleitner AA; Farooqi AA
    Asian Pac J Cancer Prev; 2014; 15(9):3865-71. PubMed ID: 24935565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
    Wang S; Su R; Nie S; Sun M; Zhang J; Wu D; Moustaid-Moussa N
    J Nutr Biochem; 2014 Apr; 25(4):363-76. PubMed ID: 24406273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics.
    Patra S; Pradhan B; Nayak R; Behera C; Rout L; Jena M; Efferth T; Bhutia SK
    Semin Cancer Biol; 2021 Aug; 73():310-320. PubMed ID: 33152486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.
    Dandawate PR; Subramaniam D; Jensen RA; Anant S
    Semin Cancer Biol; 2016 Oct; 40-41():192-208. PubMed ID: 27609747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin and liver cancer: a review.
    Darvesh AS; Aggarwal BB; Bishayee A
    Curr Pharm Biotechnol; 2012 Jan; 13(1):218-28. PubMed ID: 21466422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.